MFDS
- Marketing authorisation holder: PROVEPHARM SAS
- Status: likely_approved
🇰🇷 Bludigo in South Korea
Bludigo (INDIGOTINDISULFONATE) regulatory status in South Korea.
Marketing authorisation
Bludigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Bludigo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Bludigo in South Korea?
PROVEPHARM SAS holds the South Korean marketing authorisation.